202 related articles for article (PubMed ID: 23124847)
1. Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer.
Cha EK; Tirsar LA; Schwentner C; Hennenlotter J; Christos PJ; Stenzl A; Mian C; Martini T; Pycha A; Shariat SF; Schmitz-Dräger BJ
World J Urol; 2012 Dec; 30(6):847-52. PubMed ID: 23124847
[TBL] [Abstract][Full Text] [Related]
2. Immunocytology is a strong predictor of bladder cancer presence in patients with painless hematuria: a multicentre study.
Cha EK; Tirsar LA; Schwentner C; Christos PJ; Mian C; Hennenlotter J; Martini T; Stenzl A; Pycha A; Shariat SF; Schmitz-Dräger BJ
Eur Urol; 2012 Jan; 61(1):185-92. PubMed ID: 21924544
[TBL] [Abstract][Full Text] [Related]
3. Prospective external validation of a bladder cancer detection model.
Lotan Y; Svatek RS; Krabbe LM; Xylinas E; Klatte T; Shariat SF
J Urol; 2014 Nov; 192(5):1343-8. PubMed ID: 24859442
[TBL] [Abstract][Full Text] [Related]
4. Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection.
Lotan Y; Capitanio U; Shariat SF; Hutterer GC; Karakiewicz PI
BJU Int; 2009 May; 103(10):1368-74. PubMed ID: 19338566
[TBL] [Abstract][Full Text] [Related]
5. The Prevalence of Bladder Cancer During Cystoscopy for Asymptomatic Microscopic Hematuria.
Gonzalez AN; Lipsky MJ; Li G; Rutman MP; Cooper KL; Weiner DM; Badalato G; Decastro GJ; Wenske S; McKiernan JM; Anderson CB
Urology; 2019 Apr; 126():34-38. PubMed ID: 30677457
[TBL] [Abstract][Full Text] [Related]
6. Detection of Upper Tract Urothelial Malignancies by Computed Tomography Urography in Patients Referred for Hematuria at a Large Tertiary Referral Center.
Commander CW; Johnson DC; Raynor MC; Burke LM; Hacker KE; Hoag B; Fielding JR; Semelka RC; Lee ER
Urology; 2017 Apr; 102():31-37. PubMed ID: 28088432
[TBL] [Abstract][Full Text] [Related]
7. A simplified nomogram to assess risk of bladder cancer in patients with a new diagnosis of microscopic hematuria.
Matulewicz RS; Rademaker A; Meeks JJ
Urol Oncol; 2020 Apr; 38(4):240-246. PubMed ID: 31952999
[TBL] [Abstract][Full Text] [Related]
8. Assessment of asymptomatic microscopic hematuria in adults.
Sharp VJ; Barnes KT; Erickson BA
Am Fam Physician; 2013 Dec; 88(11):747-54. PubMed ID: 24364522
[TBL] [Abstract][Full Text] [Related]
9. Asymptomatic microscopic hematuria as a predictor of neoplasia in the urinary tract.
Ordell Sundelin M; Jensen JB
Scand J Urol; 2017 Oct; 51(5):373-375. PubMed ID: 28644736
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC
BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
[TBL] [Abstract][Full Text] [Related]
11. Gender disparities in hematuria evaluation and bladder cancer diagnosis: a population based analysis.
Garg T; Pinheiro LC; Atoria CL; Donat SM; Weissman JS; Herr HW; Elkin EB
J Urol; 2014 Oct; 192(4):1072-7. PubMed ID: 24835058
[TBL] [Abstract][Full Text] [Related]
12. Utility of urine cytology in the workup of asymptomatic microscopic hematuria in low-risk patients.
Feifer AH; Steinberg J; Tanguay S; Aprikian AG; Brimo F; Kassouf W
Urology; 2010 Jun; 75(6):1278-82. PubMed ID: 20138655
[TBL] [Abstract][Full Text] [Related]
13. Predicting bladder cancer risk in patients with hematuria. A single-centre retrospective study.
Jarimba R; Quaresma V; Pedroso Lima J; Eliseu M; Tavares da Silva E; Moreira P; Figueiredo A
Arch Ital Urol Androl; 2023 Mar; 95(1):11026. PubMed ID: 36924379
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of an Epigenetic Profile for the Detection of Bladder Cancer in Patients with Hematuria.
van Kessel KE; Van Neste L; Lurkin I; Zwarthoff EC; Van Criekinge W
J Urol; 2016 Mar; 195(3):601-7. PubMed ID: 26327355
[TBL] [Abstract][Full Text] [Related]
15. Sex and the Diagnostic Pathway to Bladder Cancer among Veterans: No Evidence of Disparity.
Lynch KE; Viernes B; Khader K; DuVall SL; Schroeck FR
Womens Health Issues; 2020; 30(2):128-135. PubMed ID: 31870696
[TBL] [Abstract][Full Text] [Related]
16. HOXA9, PCDH17, POU4F2, and ONECUT2 as a Urinary Biomarker Combination for the Detection of Bladder Cancer in Chinese Patients with Hematuria.
Wu Y; Jiang G; Zhang N; Liu S; Lin X; Perschon C; Zheng SL; Ding Q; Wang X; Na R; Sun J; Xu J
Eur Urol Focus; 2020 Mar; 6(2):284-291. PubMed ID: 30309818
[TBL] [Abstract][Full Text] [Related]
17. Novel nomograms to predict recurrence and progression in primary non-muscle-invasive bladder cancer: validation of predictive efficacy in comparison with European Organization of Research and Treatment of Cancer scoring system.
Kim HS; Jeong CW; Kwak C; Kim HH; Ku JH
World J Urol; 2019 Sep; 37(9):1867-1877. PubMed ID: 30535715
[TBL] [Abstract][Full Text] [Related]
18. Can reproductive characteristics predict bladder cancer in women with haematuria?
Yavuzcan A; Caglar M; Kayikci MA; Basaran E; Tekin A; Ozdemir E; Dilbaz S; Ustun Y; Cam HK
Asian Pac J Cancer Prev; 2013; 14(9):5107-10. PubMed ID: 24175784
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and significant predictors of detecting underlying diseases in adults with asymptomatic microscopic hematuria: a large case series of a Korean population.
Kang M; Lee S; Jeong SJ; Hong SK; Byun SS; Lee SE; Jeong CW
Int J Urol; 2015 Apr; 22(4):389-93. PubMed ID: 25581719
[TBL] [Abstract][Full Text] [Related]
20. Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria.
Loo RK; Lieberman SF; Slezak JM; Landa HM; Mariani AJ; Nicolaisen G; Aspera AM; Jacobsen SJ
Mayo Clin Proc; 2013 Feb; 88(2):129-38. PubMed ID: 23312369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
